Leukocyte Telomere Length as Potential Biomarker of HD Progression: A Follow-Up Study

The identification of biomarkers for neurodegenerative disorders such as Huntington’s disease (HD) is crucial for monitoring disease progression and therapeutic trial outcomes, especially in the pre-manifest disease stage (pre-HD). In a previous study, we observed that leukocyte telomere length (LTL...

Descripción completa

Detalles Bibliográficos
Autores principales: Scarabino, Daniela, Veneziano, Liana, Mantuano, Elide, Arisi, Ivan, Fiore, Alessia, Frontali, Marina, Corbo, Rosa Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654348/
https://www.ncbi.nlm.nih.gov/pubmed/36362235
http://dx.doi.org/10.3390/ijms232113449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654348/
https://www.ncbi.nlm.nih.gov/pubmed/36362235
http://dx.doi.org/10.3390/ijms232113449

Ejemplares similares